|
PRF1
|
OGG_3000005551 |
|
|
thrombophilia
|
DOID_2452 |
[A condition characterized by an abnormally high level of thrombi. Causes include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, bone marrow disorders, and antiphospholipid antibody syndrome.] |
|
blood coagulation disease
|
DOID_1247 |
[A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.] |
|
renin-angiotensin system
|
UBERON_0018229 |
[A system consisting of renin, angiotensin-converting enzyme, and angiotensin II. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex.] |
|
organ system subdivision
|
UBERON_0011216 |
[A subdivision of an anatomical system.] |
|
Lung Infection, CTCAE
|
NCIT_C143657 |
[A disorder characterized by an infectious process involving the lungs, including pneumonia.] |
|
immunoglobulin complex
|
GO_0019814 |
[A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.] |
|
vasculitis
|
SYMP_0000153 |
|
|
positive COVID-19 test
|
COVID_0000044 |
|
|
Interlobular septal thickening on pulmonary HRCT
|
HP_0030879 |
[Presence of thickening of the interlobular septa of the lungs as seen on a CT scan.] |
|
Pulmonary interstitial high-resolution computed tomography abnormality
|
HP_0025389 |
[High-resolution computed tomography (HRCT) can distinguish findings that characterize characterise interstitial lung diseases in a way not possible with other modalities.] |
|
acute brain injury
|
COVID_0000043 |
|
|
transmission to healthcare workers
|
COVID_0000042 |
|
|
analysis of SARS-CoV-2 host interacting proteins
|
COVID_0000041 |
|
|
A2a1 haplotype
|
COVID_0000040 |
[A2a1 haplotype of SARS CoV2] |
|
tolazamide
|
CHEBI_9613 |
[An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.] |
|
severe acute respiratory syndrome coronavirus 2
|
COVID_0000049 |
|
|
lumen stenosis
|
COVID_0000048 |
|
|
clusters of COVID-19
|
COVID_0000047 |
|
|
B1a1 haplotype
|
COVID_0000046 |
[B1a1 haplotype of SARS CoV2] |